IKBKE and glioblastoma: Of these, IKBKE (inhibitor of nuclear factor kappa-B kinase subunit epsilon) and YBX1 (Y box binding protein 1) have been previously implicated in glioblastoma pathogenesis and metabolic targeting of virotherapy11,12.